Mehtap Tatar

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

Iron Deficiency

Coronary Artery Bypass

Top Venues

Advances in therapy

ClinicoEconomics and outcomes research : CEOR

This page only lists publications with an associated author ORCID identifier.

Publications

Laser Şanal, Serdar Günaydin, Mehtap Tatar
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey. Advances in therapy 41 (2) (2023)
Laser Şanal, Serdar Günaydin, Mehtap Tatar
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey. Advances in therapy 41 (2) (2023)
Laser Şanal, Serdar Günaydin, Mehtap Tatar
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey. Advances in therapy (2023)
Laser Şanal, Serdar Günaydin, Mehtap Tatar
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey. Advances in therapy 41 (2) (2023)
Laser Şanal, Serdar Günaydin, Mehtap Tatar
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey. Advances in therapy 41 (2) (2023)
Laser Şanal, Serdar Günaydin, Mehtap Tatar
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey. Advances in therapy 41 (2) (2023)
Mehtap Tatar, Neslihan Alkış, Çiğdem Yıldırım Güçlü, Ahmet Onat Bermede, Bülent Erdemli, Serdar Günaydin
Cost-Effectiveness and Budget Impact of Comprehensive Anemia Management, The First Pillar of Patient Blood Management, on the Turkish Healthcare System. ClinicoEconomics and outcomes research : CEOR 14 (2022)